MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 02-21-2026
BeyondSpring Shares 2011-2026 | BYSI
Annual Shares BeyondSpring
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.3 M | 39 M | 39.1 M | 39 M | 30 M | 24.6 M | 22.7 M | 20.9 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40.3 M | 20.9 M | 32 M |
Quarterly Shares BeyondSpring
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.3 M | 40.3 M | 40.3 M | 40.3 M | 40.3 M | 39.3 M | 39 M | - | - | - | - | 38.9 M | 39 M | 39 M | 39 M | 39.1 M | 30.3 M | 27.9 M | 27.7 M | 27.9 M | 25.3 M | 23.1 M | 23 M | 23.2 M | 23 M | 22.4 M | 22.2 M | 22.5 M | 22.8 M | 21.7 M | 17.8 M | 16.9 M | 16 M | - | 15.8 M | 15.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 40.3 M | 15.8 M | 29 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M |  USA |
 |
I-Mab
IMAB
|
187 M | - | - | $ 866 M |  China |
 |
Grifols, S.A.
GRFS
|
682 M | $ 9.0 | 0.47 % | $ 6.83 B |  Spain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | USA |
 |
Ascendis Pharma A/S
ASND
|
54.8 M | $ 232.12 | 1.37 % | $ 5 B |  Danmark |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
argenx SE
ARGX
|
51.1 M | $ 762.4 | -1.18 % | $ 25 B |  Niderland |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.47 | -1.73 % | $ 8.35 B |  Australia |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M |  Canada |
 |
ADMA Biologics
ADMA
|
238 M | $ 15.38 | 1.32 % | $ 3.67 B | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
152 M | $ 16.0 | -2.79 % | $ 2.43 B | USA |
 |
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Alkermes plc
ALKS
|
165 M | $ 30.02 | -2.31 % | $ 4.94 B |  Irlanda |
 |
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | Canada |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
46.7 M | $ 20.19 | -23.78 % | $ 944 M | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | USA |
 |
Aptose Biosciences
APTO
|
699 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | USA |
 |
Athira Pharma
ATHA
|
38.5 M | - | - | $ 269 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
244 M | $ 109.93 | 1.04 % | $ 27.2 B | Germany |
 |
Arena Pharmaceuticals
ARNA
|
60.8 M | - | -6.81 % | $ 3.04 B | USA |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
134 M | $ 14.1 | 0.89 % | $ 1.89 B | Canada |
 |
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | USA |
 |
Axcella Health
AXLA
|
54.4 M | - | -16.42 % | $ 249 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 8.4 | -1.35 % | $ 1.38 B | Britain |
 |
Axsome Therapeutics
AXSM
|
49.7 M | $ 163.5 | 0.19 % | $ 8.13 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
255 M | $ 1.71 | -3.67 % | $ 436 M | Britain |
 |
Aytu BioScience
AYTU
|
6.28 M | $ 2.57 | 4.47 % | $ 16.1 M | USA |